Literature DB >> 2387158

Distractibility in early Parkinson's disease.

M H Sharpe1.   

Abstract

Post-mortem evidence has shown a depletion of dopamine in the mesocortical and mesolimbic pathways in brains of Parkinson patients. Since these dopaminergic pathways have been implicated in the control of attention in animals, selective attention to visual stimuli was studied in eight patients with early Parkinson's disease (Stage I or II as defined by the Hoehn and Yahr Scale) and eight normal controls of comparable age, sex and Full Scale Intelligence Quotient. Subjects with dementia, psychiatric disease and other neurological abnormalities were excluded. The Parkinson patients were more prone to interference in the presence of distractor items than the normal controls as shown on the focussing + distraction and switching + distraction of attention paradigms on the Distractor task. There findings are not accounted for by mood, intellectual status or memory and thus may be as a result of the loss of dopamine in the mesocortico-limbic projections.

Entities:  

Mesh:

Year:  1990        PMID: 2387158     DOI: 10.1016/s0010-9452(13)80353-x

Source DB:  PubMed          Journal:  Cortex        ISSN: 0010-9452            Impact factor:   4.027


  13 in total

1.  The role of the substantia nigra in cognitive activity in cats.

Authors:  E I Mukhin; Yu K Mukhina; T N Nabieva
Journal:  Neurosci Behav Physiol       Date:  2004-03

2.  Alzheimer-type dementia and verbal memory performances: influence of selegiline therapy.

Authors:  G Finali; M Piccirilli; C Oliani; G L Piccinin
Journal:  Ital J Neurol Sci       Date:  1992-03

3.  Behavioral toxicology of cognition: extrapolation from experimental animal models to humans: behavioral toxicology symposium overview.

Authors:  Merle G Paule; Leonard Green; Joel Myerson; Maria Alvarado; Jocelyne Bachevalier; Jay S Schneider; Susan L Schantz
Journal:  Neurotoxicol Teratol       Date:  2012-01-28       Impact factor: 3.763

4.  Effects of stimulus-response compatibility in Parkinson's disease: a psychophysiological analysis.

Authors:  M Falkenstein; R Willemssen; J Hohnsbein; H Hielscher
Journal:  J Neural Transm (Vienna)       Date:  2006-02-09       Impact factor: 3.575

Review 5.  Rule-based category learning in patients with Parkinson's disease.

Authors:  Amanda Price; J Vincent Filoteo; W Todd Maddox
Journal:  Neuropsychologia       Date:  2009-02-02       Impact factor: 3.139

6.  Cortical and subcortical contributions to state- and strength-based perceptual judgments.

Authors:  Mariam Aly; Murielle Wansard; Fermín Segovia; Andrew P Yonelinas; Christine Bastin
Journal:  Neuropsychologia       Date:  2014-09-22       Impact factor: 3.139

7.  Diminished EEG habituation to novel events effectively classifies Parkinson's patients.

Authors:  James F Cavanagh; Praveen Kumar; Andrea A Mueller; Sarah Pirio Richardson; Abdullah Mueen
Journal:  Clin Neurophysiol       Date:  2017-12-13       Impact factor: 3.708

8.  Executive function deficits and glutamatergic protein alterations in a progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease.

Authors:  Lacey Pflibsen; Katherine A Stang; Michelle D Sconce; Vanessa B Wilson; Rebecca L Hood; Charles K Meshul; Suzanne H Mitchell
Journal:  J Neurosci Res       Date:  2015-08-31       Impact factor: 4.164

9.  A central executive deficit in patients with Parkinson's disease.

Authors:  J C Dalrymple-Alford; A S Kalders; R D Jones; R W Watson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-03       Impact factor: 10.154

10.  Interaction between nicotinic and dopaminergic therapies on cognition in a chronic Parkinson model.

Authors:  E Decamp; J S Schneider
Journal:  Brain Res       Date:  2009-02-07       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.